> This patent describes a generic architecture for a machine that automates testing for the presence of substances in bodily fluids. In the system described by

> This patent describes a generic architecture for a machine that automates testing for the presence of substances in bodily fluids. In the system described by the patent, an operator inserts a "test device" (which contains both the bodily fluid to be tested and the reactants required to perform the test) into a "reader device." The reader device then triggers the necessary chemical reactions to perform the test and reports the results. Theranos' patent isn't limited to any specific bodily fluid, reactants, or testing protocol. !